Boston Scientific designs and manufactures implantable and minimally invasive medical devices used by physicians to diagnose and treat cardiovascular, endoscopic, urological, neurological, and other conditions. It sells these products and related therapies to hospitals and health systems worldwide through a direct sales model and distributors. Founded in 1979 and headquartered in Marlborough, Massachusetts, it is publicly traded on the NYSE (BSX) with offerings spanning stents, catheters, electrophysiology, and neuromodulation systems.